ProfileGDS4718 / 235372_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 68% 70% 61% 65% 66% 66% 66% 72% 76% 65% 57% 86% 60% 60% 62% 68% 65% 62% 66% 66% 66% 64% 59% 68% 75% 59% 57% 60% 59% 67% 72% 61% 73% 70% 61% 61% 64% 76% 79% 59% 68% 64% 62% 66% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.7389368
GSM549102patient 115, normal, homogenized [OPG study]6.8474970
GSM549104patient 119, normal, homogenized [OPG study]6.2170261
GSM549108patient 138, normal, homogenized [OPG study]6.4868465
GSM549119patient 077, normal, homogenized [OPG study]6.5566366
GSM549133patient 032, cancer, homogenized [OPG study]6.5552766
GSM549139patient 042, cancer, homogenized [OPG study]6.5351766
GSM549099patient 107, normal, homogenized [OPG study]7.0279972
GSM549109patient 139, normal, homogenized [OPG study]7.3352276
GSM549110patient 046, normal, homogenized [OPG study]6.4413265
GSM549114patient 063, normal, homogenized [OPG study]5.8669157
GSM549122patient 082, normal, homogenized [OPG study]8.6540186
GSM549134patient 033, cancer, homogenized [OPG study]6.0709560
GSM549136patient 036, cancer, homogenized [OPG study]6.0831760
GSM549140patient 044, cancer, homogenized [OPG study]6.254562
GSM549111patient 047, normal, homogenized [OPG study]6.7711368
GSM549113patient 057, normal, homogenized [OPG study]6.4602865
GSM549132patient 031, cancer, homogenized [OPG study]6.2290362
GSM549137patient 038, cancer, homogenized [OPG study]6.5999966
GSM549142patient 047, cancer, homogenized [OPG study]6.5635166
GSM549100patient 110, normal, homogenized [OPG study]6.5192266
GSM549107patient 135, normal, homogenized [OPG study]6.4063764
GSM549115patient 068, normal, homogenized [OPG study]6.0280459
GSM549116patient 072, normal, homogenized [OPG study]6.7058968
GSM549120patient 078, normal, homogenized [OPG study]7.2912475
GSM549131patient 030, cancer, homogenized [OPG study]6.0336559
GSM549118patient 074, normal, homogenized [OPG study]5.9354357
GSM549129patient 027, cancer, homogenized [OPG study]6.1428260
GSM549123patient 088, normal, homogenized [OPG study]6.0787159
GSM549124patient 006, cancer, homogenized [OPG study]6.6275767
GSM549126patient 015, cancer, homogenized [OPG study]7.0904472
GSM549128patient 025, cancer, homogenized [OPG study]6.1986561
GSM549103patient 117, normal, homogenized [OPG study]7.0604873
GSM549117patient 073, normal, homogenized [OPG study]6.7898970
GSM549138patient 041, cancer, homogenized [OPG study]6.1979761
GSM549141patient 045, cancer, homogenized [OPG study]6.2241861
GSM549130patient 028, cancer, homogenized [OPG study]6.3840664
GSM549101patient 111, normal, homogenized [OPG study]7.4558976
GSM549105patient 128, normal, homogenized [OPG study]7.7390979
GSM549106patient 134, normal, homogenized [OPG study]6.0297459
GSM549112patient 048, normal, homogenized [OPG study]6.7133268
GSM549125patient 011, cancer, homogenized [OPG study]6.409464
GSM549127patient 024, cancer, homogenized [OPG study]6.2992962
GSM549135patient 035, cancer, homogenized [OPG study]6.6122266